Answers are grounded in this paper and cite their sources.
Cancer is one of the fatal diseases diagnosed among people globally. Proactive cancer prediction is a complex and challenging research problem that requires the potential analysis of large multimodal data, including patient medical records, numeric and imaging data, and genomic data. According to the World Health Organization (WHO) Global Health Estimate (GHE)-2020, which was conducted over 180 countries, non-communicable disease categories include multiple subcategories, of which all cancer types account for 16.8% of global deaths, making it the second leading cause of death after cardiovascular diseases [1]. Accounting for 2020, it is estimated that nearly 10 million people died from cancer, which is approximately one in six deaths. According to the International Agency of Research on Cancer (IARC), it is predicted that the approximate incidence and mortality counts will rise to 29.5 million and 16.4 million, respectively, by the year 2040 [2].
No takes yet. Share an insight, caveat, or question.
G et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: